2019
DOI: 10.1038/s41598-019-50221-0
|View full text |Cite
|
Sign up to set email alerts
|

Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion

Abstract: The accumulation of advanced glycation end products (AGEs) have been implicated in the development and progression of diabetic kidney disease (DKD). There has been interest in investigating the potential of AGE clearance receptors, such as oligosaccharyltransferase-48 kDa subunit (OST48) to prevent the detrimental effects of excess AGE accumulation seen in the diabetic kidney. Here the objective of the study was to increase the expression of OST48 to examine if this slowed the development of DKD by facilitatin… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 57 publications
0
3
0
Order By: Relevance
“…One of this receptor is AGER1, also known as OCT48, which lowers AGEs and facilitates its clearance into urine ( Vlassara et al, 2009b ; Uribarri et al, 2011 ) and is known as an anti-inflammatory AGE receptor ( Lu et al, 2004 ); it is downregulated in many autoimmune diseases such as CDK and diabetes ( Stinghen et al, 2016 ). Although AGER1 receptor’s over-expression clears AGE burden, it leads to tubulointerstitial damage and fibrosis ( Zhuang et al, 2019 ). Similarly, when overexpressed in mice podocytes, glomerulosclerosis and podocyte injury result despite AGE clearance ( Zhuang et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…One of this receptor is AGER1, also known as OCT48, which lowers AGEs and facilitates its clearance into urine ( Vlassara et al, 2009b ; Uribarri et al, 2011 ) and is known as an anti-inflammatory AGE receptor ( Lu et al, 2004 ); it is downregulated in many autoimmune diseases such as CDK and diabetes ( Stinghen et al, 2016 ). Although AGER1 receptor’s over-expression clears AGE burden, it leads to tubulointerstitial damage and fibrosis ( Zhuang et al, 2019 ). Similarly, when overexpressed in mice podocytes, glomerulosclerosis and podocyte injury result despite AGE clearance ( Zhuang et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Many factors can lead to renal fibrosis in DKD, such as AGEs, mitochondrial dysfunction, autophagy dysfunction, activation of inflammatory pathway and so on (37)(38)(39). AGEs is considered to be an important factor in the process of DKD renal fibrosis, which can promote the process by stimulating the secretion of oxygen free radicals, cytokines, chemokines, adhesion molecules, TGF-β, CTGF, and other mediators (15,40). Therefore, the current study is conducted to reveal the mechanism of renal tubulointerstitial fibrosis induced by AGEs with the conclusion pronouncing that AGEs reduce the fibrosis progression in DKD through the JMJD1A/NR4A1 axis.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, oral administration of mannose suppressed the immunopathology in models of autoimmune diabetes and airway inflammation [12]. However, high dosage of mannose could cause injury towards the kidneys [13]. Furthermore, the scientific evidence on the cell viability pattern of the normal and cancer cell lines that were treated with mannose is insufficient.…”
Section: Introductionmentioning
confidence: 99%